Fusing Omics and Advanced Cell Models: A New Era for Drug Discovery and Reproducibility
July 10, 2025, at 12:00 PM ETThe way we discover and develop new therapies is changing—fast. Thanks to advances in omics technologies and newer cell models that closely recapitulate primary cells and tissue, researchers now have powerful tools to better understand biology and disease. In this webinar, we’ll explore how combining omics data—like genomics, and transcriptomics —with cutting-edge 2D and 3D cell models is opening new doors in drug discovery and helping to tackle the long-standing challenge of reproducibility. Join us as we dive into real-world examples, share emerging tools, and discuss how these integrated approaches are making research more predictive, more reliable, and ultimately more impactful.
Key Points:
1. See more, know more—learn how combining omics with advanced cell models gives richer insights into biology and disease.
2. Make results stick—discover how these models boost reproducibility and reduce variability across studies.
3. Move faster, smarter—explore how this approach speeds up discovery and brings better therapies closer to the clinic.
Presenters
Ajeet Singh, PhD
Senior Scientist, ATCC
Dr. Ajeet Singh is Senior Scientist at ATCC where he is focused on providing reference-grade whole transcriptome data that is authenticated, standard, and traceable to physical source materials available in ATCC’s biorepository. Prior to joining ATCC, Dr. Singh received his PhD in Agricultural Plant Pathology where he performed research focused on epidemiology and integrated management of plants pests and diseases. He then performed postdoctoral research at the National Institute of Environmental Health Sciences and subsequently worked as a Senior Staff Scientist at the National Cancer Institute. Dr. Singh has extensive experience in biomedical research with his research career expanding an array of interrelated disciplines exploring epigenetics, chromatin and gene expression in reproductive developmental toxicology, stem cell biology, and cancer.
